The compound works by selectively inhibiting the carbonic anhydrase enzyme in the ciliary processes of the eye, which reduces the production of aqueous humor and consequently lowers the pressure inside the eye. This mechanism is distinct from other glaucoma treatments like prostaglandin analogs, making it a valuable option for combination therapy.
Dorzolamide HCl is known for its good solubility in water, which is essential for the development of effective topical eye solutions.
As a key starting material or API, its quality, purity, and stability are critically controlled during the manufacturing process to ensure the safety and efficacy of the final medicinal product.
Ophthalmic